Altered oligodendrocyte maturation and myelin maintenance

The role of antiretrovirals in HIV-associated neurocognitive disorders

Brigid K. Jensen, Hubert Monnerie, Maggie V. Mannell, Patrick J. Gannon, Cagla Akay Espinoza, Michelle A. Erickson, Annadora J. Bruce-Keller, Benjamin Gelman, Lisa A. Briand, R. Christopher Pierce, Kelly L. Jordan-Sciutto, Judith B. Grinspan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Despite effective viral suppression through combined antiretroviral therapy (cART), approximately half of HIV-positive individuals have HIV-associated neurocognitive disorders (HAND). Studies of antiretroviral-treated patients have revealed persistent white matter abnormalities including diffuse myelin pallor, diminished white matter tracts, and decreased myelin protein mRNAs. Loss of myelin can contribute to neurocognitive dysfunction because the myelin membrane generated by oligodendrocytes is essential for rapid signal transduction and axonal maintenance. We hypothesized that myelin changes in HAND are partly due to effects of antiretroviral drugs on oligodendrocyte survival and/or maturation. We showed that primary mouse oligodendrocyte precursor cell cultures treated with therapeutic concentrations of HIV protease inhibitors ritonavir or lopinavir displayed dose-dependent decreases in oligodendrocyte maturation; however, this effect was rapidly reversed after drug removal. Conversely, nucleoside reverse transcriptase inhibitor zidovudine had no effect. Furthermore, in vivo ritonavir administration to adult mice reduced frontal cortex myelin protein levels. Finally, prefrontal cortex tissue from HIV-positive individuals with HAND on cART showed a significant decrease in myelin basic protein compared with untreated HIV-positive individuals with HAND or HIV-negative controls. These findings demonstrate that antiretrovirals can impact myelin integrity and have implications for myelination in juvenile HIV patients and myelin maintenance in adults on lifelong therapy.

Original languageEnglish (US)
Pages (from-to)1093-1118
Number of pages26
JournalJournal of Neuropathology and Experimental Neurology
Volume74
Issue number11
StatePublished - 2015

Fingerprint

Oligodendroglia
Myelin Sheath
Maintenance
HIV
Myelin Proteins
Ritonavir
Lopinavir
HIV Protease Inhibitors
Pallor
Neurocognitive Disorders
Reverse Transcriptase Inhibitors
Myelin Basic Protein
Zidovudine
Frontal Lobe
Therapeutics
Prefrontal Cortex
Nucleosides
Pharmaceutical Preparations
Signal Transduction
Cell Culture Techniques

Keywords

  • Antiretroviral
  • HIV
  • HIV-Associated neurocognitive Disorders
  • Myelin
  • Oligodendrocyte
  • Pediatric AIDS
  • Protease inhibitor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Jensen, B. K., Monnerie, H., Mannell, M. V., Gannon, P. J., Espinoza, C. A., Erickson, M. A., ... Grinspan, J. B. (2015). Altered oligodendrocyte maturation and myelin maintenance: The role of antiretrovirals in HIV-associated neurocognitive disorders. Journal of Neuropathology and Experimental Neurology, 74(11), 1093-1118.

Altered oligodendrocyte maturation and myelin maintenance : The role of antiretrovirals in HIV-associated neurocognitive disorders. / Jensen, Brigid K.; Monnerie, Hubert; Mannell, Maggie V.; Gannon, Patrick J.; Espinoza, Cagla Akay; Erickson, Michelle A.; Bruce-Keller, Annadora J.; Gelman, Benjamin; Briand, Lisa A.; Pierce, R. Christopher; Jordan-Sciutto, Kelly L.; Grinspan, Judith B.

In: Journal of Neuropathology and Experimental Neurology, Vol. 74, No. 11, 2015, p. 1093-1118.

Research output: Contribution to journalArticle

Jensen, BK, Monnerie, H, Mannell, MV, Gannon, PJ, Espinoza, CA, Erickson, MA, Bruce-Keller, AJ, Gelman, B, Briand, LA, Pierce, RC, Jordan-Sciutto, KL & Grinspan, JB 2015, 'Altered oligodendrocyte maturation and myelin maintenance: The role of antiretrovirals in HIV-associated neurocognitive disorders', Journal of Neuropathology and Experimental Neurology, vol. 74, no. 11, pp. 1093-1118.
Jensen, Brigid K. ; Monnerie, Hubert ; Mannell, Maggie V. ; Gannon, Patrick J. ; Espinoza, Cagla Akay ; Erickson, Michelle A. ; Bruce-Keller, Annadora J. ; Gelman, Benjamin ; Briand, Lisa A. ; Pierce, R. Christopher ; Jordan-Sciutto, Kelly L. ; Grinspan, Judith B. / Altered oligodendrocyte maturation and myelin maintenance : The role of antiretrovirals in HIV-associated neurocognitive disorders. In: Journal of Neuropathology and Experimental Neurology. 2015 ; Vol. 74, No. 11. pp. 1093-1118.
@article{67da296d3f034e04b3f94962f09a3248,
title = "Altered oligodendrocyte maturation and myelin maintenance: The role of antiretrovirals in HIV-associated neurocognitive disorders",
abstract = "Despite effective viral suppression through combined antiretroviral therapy (cART), approximately half of HIV-positive individuals have HIV-associated neurocognitive disorders (HAND). Studies of antiretroviral-treated patients have revealed persistent white matter abnormalities including diffuse myelin pallor, diminished white matter tracts, and decreased myelin protein mRNAs. Loss of myelin can contribute to neurocognitive dysfunction because the myelin membrane generated by oligodendrocytes is essential for rapid signal transduction and axonal maintenance. We hypothesized that myelin changes in HAND are partly due to effects of antiretroviral drugs on oligodendrocyte survival and/or maturation. We showed that primary mouse oligodendrocyte precursor cell cultures treated with therapeutic concentrations of HIV protease inhibitors ritonavir or lopinavir displayed dose-dependent decreases in oligodendrocyte maturation; however, this effect was rapidly reversed after drug removal. Conversely, nucleoside reverse transcriptase inhibitor zidovudine had no effect. Furthermore, in vivo ritonavir administration to adult mice reduced frontal cortex myelin protein levels. Finally, prefrontal cortex tissue from HIV-positive individuals with HAND on cART showed a significant decrease in myelin basic protein compared with untreated HIV-positive individuals with HAND or HIV-negative controls. These findings demonstrate that antiretrovirals can impact myelin integrity and have implications for myelination in juvenile HIV patients and myelin maintenance in adults on lifelong therapy.",
keywords = "Antiretroviral, HIV, HIV-Associated neurocognitive Disorders, Myelin, Oligodendrocyte, Pediatric AIDS, Protease inhibitor",
author = "Jensen, {Brigid K.} and Hubert Monnerie and Mannell, {Maggie V.} and Gannon, {Patrick J.} and Espinoza, {Cagla Akay} and Erickson, {Michelle A.} and Bruce-Keller, {Annadora J.} and Benjamin Gelman and Briand, {Lisa A.} and Pierce, {R. Christopher} and Jordan-Sciutto, {Kelly L.} and Grinspan, {Judith B.}",
year = "2015",
language = "English (US)",
volume = "74",
pages = "1093--1118",
journal = "Journal of Neuropathology and Experimental Neurology",
issn = "0022-3069",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Altered oligodendrocyte maturation and myelin maintenance

T2 - The role of antiretrovirals in HIV-associated neurocognitive disorders

AU - Jensen, Brigid K.

AU - Monnerie, Hubert

AU - Mannell, Maggie V.

AU - Gannon, Patrick J.

AU - Espinoza, Cagla Akay

AU - Erickson, Michelle A.

AU - Bruce-Keller, Annadora J.

AU - Gelman, Benjamin

AU - Briand, Lisa A.

AU - Pierce, R. Christopher

AU - Jordan-Sciutto, Kelly L.

AU - Grinspan, Judith B.

PY - 2015

Y1 - 2015

N2 - Despite effective viral suppression through combined antiretroviral therapy (cART), approximately half of HIV-positive individuals have HIV-associated neurocognitive disorders (HAND). Studies of antiretroviral-treated patients have revealed persistent white matter abnormalities including diffuse myelin pallor, diminished white matter tracts, and decreased myelin protein mRNAs. Loss of myelin can contribute to neurocognitive dysfunction because the myelin membrane generated by oligodendrocytes is essential for rapid signal transduction and axonal maintenance. We hypothesized that myelin changes in HAND are partly due to effects of antiretroviral drugs on oligodendrocyte survival and/or maturation. We showed that primary mouse oligodendrocyte precursor cell cultures treated with therapeutic concentrations of HIV protease inhibitors ritonavir or lopinavir displayed dose-dependent decreases in oligodendrocyte maturation; however, this effect was rapidly reversed after drug removal. Conversely, nucleoside reverse transcriptase inhibitor zidovudine had no effect. Furthermore, in vivo ritonavir administration to adult mice reduced frontal cortex myelin protein levels. Finally, prefrontal cortex tissue from HIV-positive individuals with HAND on cART showed a significant decrease in myelin basic protein compared with untreated HIV-positive individuals with HAND or HIV-negative controls. These findings demonstrate that antiretrovirals can impact myelin integrity and have implications for myelination in juvenile HIV patients and myelin maintenance in adults on lifelong therapy.

AB - Despite effective viral suppression through combined antiretroviral therapy (cART), approximately half of HIV-positive individuals have HIV-associated neurocognitive disorders (HAND). Studies of antiretroviral-treated patients have revealed persistent white matter abnormalities including diffuse myelin pallor, diminished white matter tracts, and decreased myelin protein mRNAs. Loss of myelin can contribute to neurocognitive dysfunction because the myelin membrane generated by oligodendrocytes is essential for rapid signal transduction and axonal maintenance. We hypothesized that myelin changes in HAND are partly due to effects of antiretroviral drugs on oligodendrocyte survival and/or maturation. We showed that primary mouse oligodendrocyte precursor cell cultures treated with therapeutic concentrations of HIV protease inhibitors ritonavir or lopinavir displayed dose-dependent decreases in oligodendrocyte maturation; however, this effect was rapidly reversed after drug removal. Conversely, nucleoside reverse transcriptase inhibitor zidovudine had no effect. Furthermore, in vivo ritonavir administration to adult mice reduced frontal cortex myelin protein levels. Finally, prefrontal cortex tissue from HIV-positive individuals with HAND on cART showed a significant decrease in myelin basic protein compared with untreated HIV-positive individuals with HAND or HIV-negative controls. These findings demonstrate that antiretrovirals can impact myelin integrity and have implications for myelination in juvenile HIV patients and myelin maintenance in adults on lifelong therapy.

KW - Antiretroviral

KW - HIV

KW - HIV-Associated neurocognitive Disorders

KW - Myelin

KW - Oligodendrocyte

KW - Pediatric AIDS

KW - Protease inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84945231810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945231810&partnerID=8YFLogxK

M3 - Article

VL - 74

SP - 1093

EP - 1118

JO - Journal of Neuropathology and Experimental Neurology

JF - Journal of Neuropathology and Experimental Neurology

SN - 0022-3069

IS - 11

ER -